Results 61 to 70 of about 12,786 (117)

<i>Staphylococcus aureus</i> SaeR/S-regulated factors overcome human complement-mediated inhibition of aggregation to evade neutrophil killing. [PDF]

Proc Natl Acad Sci U S A
Pettygrove BA, Nygaard TK, Borgogna TR, Malachowa N, Gaur G, Salo SE, Pallister KB, Burroughs O, Robinson C, Gao A, Sturdevant DE, Ricklefs S, DeLeo FR, Otto M, Stewart PS, Voyich JM.   +15 more
europepmc   +1 more source

Association of Complement Proteins with C Reactive Protein in Non-Obese Women with and Without Polycystic Ovary Syndrome. [PDF]

Int J Mol Sci
Butler AE, Moin ASM, Begam HH, Waris S, Azeez JM, Sathyapalan T, Atkin SL, Brennan E.   +7 more
europepmc   +1 more source

Role of intrarenal complement production in kidney transplantation. [PDF]

Clin Kidney J
Molinari P, Wadnerkar S, Ferrari KL, Castellano G, Chun N, Cravedi P.   +5 more
europepmc   +1 more source

The C3b inactivator of the human complement system: homology with serine proteases

FEBS Letters, 1981
openaire   +3 more sources

Drug-resistant epilepsy associated with peripheral complement decreases and sex-specific cytokine imbalances: a pilot study. [PDF]

Sci Rep
Pinzon-Hoyos N, Li Y, McGee M, Poolos NP, Marchi N, Brewster AL.   +5 more
europepmc   +1 more source

The specific contributions of factor H and factor I in controlling fluid phase activation of the alternative complement pathway. [PDF]

Sci Rep
Turner NA, Moake JL.
europepmc   +1 more source

Factor B as a therapeutic target for the treatment of complement-mediated diseases. [PDF]

Front Immunol
Kavanagh D, Barratt J, Schubart A, Webb NJA, Meier M, Fakhouri F.   +5 more
europepmc   +1 more source

Non-canonical extracellular complement pathways and the complosome paradigm in cancer: a scoping review. [PDF]

Front Immunol
de Freitas Oliveira-Tore C, de Moraes AG, Plácido HMBS, Signorini NMDL, Fontana PD, da Piedade Batista Godoy T, Boldt ABW, de Messias I.   +7 more
europepmc   +1 more source

Dynamic Complement Protein Changes in Aqueous Humor and Plasma of Patients With Retinal Vein Occlusion During Ranibizumab Treatment. [PDF]

J Inflamm Res
Guo T, Zhao Y, Liang S, Wang J, Liu H, Zhou Y, Xu H, Chen Z.   +7 more
europepmc   +1 more source

<i>Echinococcus multilocularis</i> Calreticulin Inhibits Lectin Pathway of Complement Activation by Directly Binding to Mannose-Binding Lectin. [PDF]

Pathogens
Shao Y, Xia M, Song Y, Yan Y, Dong X, Zong H, Zhan B, Wang Y, Zhao L.   +8 more
europepmc   +1 more source